Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael Narachi files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Emil D. Kakkis - $1.24M in RARE purchases and sales in the last 12 months
- Howard Horn - $1.08M in RARE purchases and sales in the last 12 months
- Karah Herdman Parschauer - $488K in RARE purchases and sales in the last 12 months
- Erik Harris - $240K in RARE purchases and sales in the last 12 months
- John Richard Pinion - $229K in RARE purchases and sales in the last 12 months
- Eric Crombez - $169K in RARE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael Narachi?
Michael Narachi is a corporate insider of Ultragenyx Pharmaceutical Inc. (RARE). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Michael Narachi last file a Form 4?
The only primary Form 4 on record is dated 18 May 2026.
